Decreased Mdm2 expression inhibits tumor development induced by loss of ARF

P. Wang, Timothy Charles Greiner, T. Lushnikova, C. M. Eischen

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The tumor suppressor p14/p19ARF regulates Mdm2, which is known for controlling the p53 tumor suppressor. Here we report that loss of one allele of Mdm2 in cells that lack ARF resulted in a decreased rate of proliferation, fewer chromosomal aberrations, and suppression of Ras-induced transformation. Moreover, a haploinsufficiency of Mdm2 inhibited spontaneous tumor development in ARF-null mice. Remarkably, Mdm2+/-ARF-/- mice survived an average of 6 months longer than Mdm2+/+ARF-/- mice. The spectrum of tumors that arose in Mdm2+/-ARF-/- mice did not significantly differ from those that developed in mice lacking only ARF. However, the extended tumor latency allowed for the emergence of multiple primary tumors in a third of the Mdm2+/-ARF-/- mice, as compared to the single tumor type that arose in ARF-null only mice. Therefore, a decrease in Mdm2 levels restored regulation of critical cellular processes that are altered during transformation and that occur in the absence of ARF. Our findings also indicate that Mdm2 can function independently from ARF and imply that targeting Mdm2 in tumors that lack ARF expression should be an effective therapeutic approach.

Original languageEnglish (US)
Pages (from-to)3708-3718
Number of pages11
JournalOncogene
Volume25
Issue number26
DOIs
StatePublished - Jun 22 2006

Fingerprint

Neoplasms
Haploinsufficiency
Chromosome Aberrations
Alleles
Therapeutics

Keywords

  • ARF
  • Mdm2
  • Transformation
  • Tumor
  • p53

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Decreased Mdm2 expression inhibits tumor development induced by loss of ARF. / Wang, P.; Greiner, Timothy Charles; Lushnikova, T.; Eischen, C. M.

In: Oncogene, Vol. 25, No. 26, 22.06.2006, p. 3708-3718.

Research output: Contribution to journalArticle

Wang, P. ; Greiner, Timothy Charles ; Lushnikova, T. ; Eischen, C. M. / Decreased Mdm2 expression inhibits tumor development induced by loss of ARF. In: Oncogene. 2006 ; Vol. 25, No. 26. pp. 3708-3718.
@article{777badb5959c4e81966aa43c5f727c0f,
title = "Decreased Mdm2 expression inhibits tumor development induced by loss of ARF",
abstract = "The tumor suppressor p14/p19ARF regulates Mdm2, which is known for controlling the p53 tumor suppressor. Here we report that loss of one allele of Mdm2 in cells that lack ARF resulted in a decreased rate of proliferation, fewer chromosomal aberrations, and suppression of Ras-induced transformation. Moreover, a haploinsufficiency of Mdm2 inhibited spontaneous tumor development in ARF-null mice. Remarkably, Mdm2+/-ARF-/- mice survived an average of 6 months longer than Mdm2+/+ARF-/- mice. The spectrum of tumors that arose in Mdm2+/-ARF-/- mice did not significantly differ from those that developed in mice lacking only ARF. However, the extended tumor latency allowed for the emergence of multiple primary tumors in a third of the Mdm2+/-ARF-/- mice, as compared to the single tumor type that arose in ARF-null only mice. Therefore, a decrease in Mdm2 levels restored regulation of critical cellular processes that are altered during transformation and that occur in the absence of ARF. Our findings also indicate that Mdm2 can function independently from ARF and imply that targeting Mdm2 in tumors that lack ARF expression should be an effective therapeutic approach.",
keywords = "ARF, Mdm2, Transformation, Tumor, p53",
author = "P. Wang and Greiner, {Timothy Charles} and T. Lushnikova and Eischen, {C. M.}",
year = "2006",
month = "6",
day = "22",
doi = "10.1038/sj.onc.1209411",
language = "English (US)",
volume = "25",
pages = "3708--3718",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "26",

}

TY - JOUR

T1 - Decreased Mdm2 expression inhibits tumor development induced by loss of ARF

AU - Wang, P.

AU - Greiner, Timothy Charles

AU - Lushnikova, T.

AU - Eischen, C. M.

PY - 2006/6/22

Y1 - 2006/6/22

N2 - The tumor suppressor p14/p19ARF regulates Mdm2, which is known for controlling the p53 tumor suppressor. Here we report that loss of one allele of Mdm2 in cells that lack ARF resulted in a decreased rate of proliferation, fewer chromosomal aberrations, and suppression of Ras-induced transformation. Moreover, a haploinsufficiency of Mdm2 inhibited spontaneous tumor development in ARF-null mice. Remarkably, Mdm2+/-ARF-/- mice survived an average of 6 months longer than Mdm2+/+ARF-/- mice. The spectrum of tumors that arose in Mdm2+/-ARF-/- mice did not significantly differ from those that developed in mice lacking only ARF. However, the extended tumor latency allowed for the emergence of multiple primary tumors in a third of the Mdm2+/-ARF-/- mice, as compared to the single tumor type that arose in ARF-null only mice. Therefore, a decrease in Mdm2 levels restored regulation of critical cellular processes that are altered during transformation and that occur in the absence of ARF. Our findings also indicate that Mdm2 can function independently from ARF and imply that targeting Mdm2 in tumors that lack ARF expression should be an effective therapeutic approach.

AB - The tumor suppressor p14/p19ARF regulates Mdm2, which is known for controlling the p53 tumor suppressor. Here we report that loss of one allele of Mdm2 in cells that lack ARF resulted in a decreased rate of proliferation, fewer chromosomal aberrations, and suppression of Ras-induced transformation. Moreover, a haploinsufficiency of Mdm2 inhibited spontaneous tumor development in ARF-null mice. Remarkably, Mdm2+/-ARF-/- mice survived an average of 6 months longer than Mdm2+/+ARF-/- mice. The spectrum of tumors that arose in Mdm2+/-ARF-/- mice did not significantly differ from those that developed in mice lacking only ARF. However, the extended tumor latency allowed for the emergence of multiple primary tumors in a third of the Mdm2+/-ARF-/- mice, as compared to the single tumor type that arose in ARF-null only mice. Therefore, a decrease in Mdm2 levels restored regulation of critical cellular processes that are altered during transformation and that occur in the absence of ARF. Our findings also indicate that Mdm2 can function independently from ARF and imply that targeting Mdm2 in tumors that lack ARF expression should be an effective therapeutic approach.

KW - ARF

KW - Mdm2

KW - Transformation

KW - Tumor

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=33745563861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745563861&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209411

DO - 10.1038/sj.onc.1209411

M3 - Article

C2 - 16491126

AN - SCOPUS:33745563861

VL - 25

SP - 3708

EP - 3718

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 26

ER -